Skip to main content

Jaguar Health, Inc.

For the period ended Dec 31, 2025. Filed Apr 7, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Apr 7, 2026

JAGX$0.44+7.9%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

Item No. · Page No.
PART I
Item 1.Business1
Item 1A.Risk Factors30
Item 1B.Unresolved Staff Comments66
Item 1C.Cybersecurity66
Item 2.Properties67
Item 3.Legal Proceedings67
Item 4.Mine Safety Disclosure67
PART II
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities68
Item 6.Selected Financial Data71
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations72
Item 7A.Qualitative and Quantitative Disclosures About Market Risk90
Item 8.Financial Statements and Supplementary Data91
Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure162
Item 9A.Controls and Procedures162
Item 9B.Other Information162
Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections162
PART III
Item 10.Directors, Executive Officers and Corporate Governance163
Item 11.Executive Compensation163
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters163
Item 13.Certain Relationships and Related Transactions, and Director Independence163
Item 14.Principal Accountant Fees and Services163
PART IV
Item 15.Exhibits, Financial Statement Schedules164
SIGNATURES176

i

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.